MapLight Therapeutics MPLT
NASDAQ MPLT
$10.15 -0.30 (-2.87%)
At close: Sep 29, 2026 · 4:00 PM EDT

MapLight Therapeutics (MPLT) EBITDA (2024 - 2025)

Updated

MapLight Therapeutics (MPLT) reported EBITDA of -$83.22 million for Q4 2025, compared with -$22.58 million a year earlier.

Analysis

MapLight Therapeutics (MPLT) EBITDA (2024 - 2025) Analysis & Trends

For FY2025, MapLight Therapeutics posted EBITDA of -$168.48 million.

  • By year, EBITDA came in at -$82.25 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 9.10 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 8.33 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 999.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 5.09 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 4.63 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -9.70 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 5.89 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 1.30 Bn
10 MapLight Therapeutics 474.82 Mn 474.82 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -83.22 Mn
Sep 30, 2025 -31.40 Mn
Dec 31, 2024 -22.58 Mn
Sep 30, 2024 -20.69 Mn
API Access

MapLight Therapeutics EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=MPLT&period=max&api_key=YOUR_API_KEY